Dr. Jeremie Calais' work focuses on improving the outcomes of cancer patients by translating and applying novel diagnostic and therapeutic approaches. He uses Positron Emission Tomography/Computed Tomography (PET/CT) imaging for cancer phenotyping, radiation therapy planning and therapy response assessment. He leads the clinical theranostics research program at UCLA that combines radionuclide therapy and imaging.